Cargando…

P53 is Subjected to Lipoteichoic Acid-Induced Phosphorylation in the Lungs

Detalles Bibliográficos
Autores principales:	Kubra, Khadeja-Tul, Uddin, Mohammad A., Akhter, Mohammad Shohel, Barabutis, Nektarios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440968/ https://www.ncbi.nlm.nih.gov/pubmed/32844143 http://dx.doi.org/10.1055/s-0040-1714695

Ejemplares similares

P53 deficiency potentiates LPS-Induced acute lung injury in vivo
por: Uddin, Mohammad A., et al.
Publicado: (2020)

Luminespib counteracts the Kifunensine-induced lung endothelial barrier dysfunction
por: Kubra, Khadeja-Tul, et al.
Publicado: (2020)

Elucidation of the Molecular Pathways Involved in the Protective Effects of AUY-922 in LPS-Induced Inflammation in Mouse Lungs
por: Akhter, Mohammad S., et al.
Publicado: (2021)

Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption
por: Akhter, Mohammad S., et al.
Publicado: (2022)

Tunicamycin Protects against LPS-Induced Lung Injury
por: Kubra, Khadeja-Tul, et al.
Publicado: (2022)

Restoring the endothelial barrier function in the elderly
por: Barabutis, Nektarios, et al.
Publicado: (2021)

An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration
por: Akhter, Mohammad S., et al.
Publicado: (2022)

Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs
por: Akhter, Mohammad S., et al.
Publicado: (2020)

Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells
por: Kubra, Khadeja-Tul, et al.
Publicado: (2022)

Metformin in acute respiratory distress syndrome: An opinion
por: Uddin, Mohammad A., et al.
Publicado: (2021)

Effects of Heat Shock Protein 90 Inhibition In the Lungs
por: Uddin, Mohammad A., et al.
Publicado: (2020)

Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress
por: Uddin, Mohammad A., et al.
Publicado: (2021)

P53 in the impaired lungs
por: Uddin, Mohammad A., et al.
Publicado: (2020)

P53 in lung vascular barrier dysfunction
por: Barabutis, Nektarios
Publicado: (2020)

P53 in acute respiratory distress syndrome
por: Barabutis, Nektarios
Publicado: (2020)

P53, GHRH, inflammation and cancer
por: Barabutis, Nektarios, et al.
Publicado: (2018)

Unfolded Protein Response in Lung Health and Disease
por: Barabutis, Nektarios
Publicado: (2020)

Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid
por: Zadeh, Mojgan, et al.
Publicado: (2012)

Wild‐type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition
por: Barabutis, Nektarios, et al.
Publicado: (2018)

Differences in lipopolysaccharide- and lipoteichoic acid-induced cytokine/chemokine expression
por: Finney, Simon J., et al.
Publicado: (2011)

Alanylated lipoteichoic acid primer in Bacillus subtilis
por: Luo, Yu
Publicado: (2016)

A nontoxic tumour necrosis factor induced by streptococcal lipoteichoic acids.
por: Usami, H., et al.
Publicado: (1987)

Lipoteichoic Acid Inhibits Staphylococcus aureus Biofilm Formation
por: Ahn, Ki Bum, et al.
Publicado: (2018)

Structure-Based Discovery of Lipoteichoic Acid Synthase Inhibitors
por: Chee Wezen, Xavier, et al.
Publicado: (2022)

Myeloid liver kinase B1 contributes to lung inflammation induced by lipoteichoic acid but not by viable Streptococcus pneumoniae
por: Pereverzeva, Liza, et al.
Publicado: (2022)

Antitumour effects of streptococcal lipoteichoic acids on Meth A fibrosarcoma.
por: Usami, H., et al.
Publicado: (1988)

Lipoteichoic Acid in Streptomyces hygroscopicus: Structural Model and Immunomodulatory Activities
por: Cot, Marlène, et al.
Publicado: (2011)

Pathways Involved in the Synergistic Activation of Macrophages by Lipoteichoic Acid and Hemoglobin
por: Cox, Kathleen H., et al.
Publicado: (2012)

Circulating microRNA signatures in mice exposed to lipoteichoic acid
por: Hsieh, Ching-Hua, et al.
Publicado: (2013)

Lipoteichoic acid mediates binding of a Lactobacillus S-layer protein
por: Bönisch, Eva, et al.
Publicado: (2018)

Quantification of Lipoteichoic Acid in Hemodialysis Patients With Central Venous Catheters
por: Barton Pai, Amy, et al.
Publicado: (2018)

Insights into the Roles of Lipoteichoic Acids and MprF in Bacillus subtilis
por: Guyet, Aurélie, et al.
Publicado: (2023)

Myricetin blocks lipoteichoic acid-induced COX-2 expression in human gingival fibroblasts
por: Gutiérrez-Venegas, Gloria, et al.
Publicado: (2014)

Experimentally induced subclinical mastitis: are lipopolysaccharide and lipoteichoic acid eliciting similar pain responses?
por: Giovannini, Annalisa Elena Jolanda, et al.
Publicado: (2017)

Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs
por: Jung, Finn, et al.
Publicado: (2022)

Endothelial Dysfunction in Cardiorenal Conditions: Implications of Endothelial Glucocorticoid Receptor-Wnt Signaling
por: Akhter, Mohammad Shohel, et al.
Publicado: (2023)

2597. Dolichos biflorus Agglutinin Binds to Pneumococcal Teichoic Acid and Lipoteichoic Acid
por: Zhou, Meng-Lan, et al.
Publicado: (2019)

Characterization and localization of the enzymatic deacylation of lipoteichoic acid in group A streptococci
Publicado: (1979)

Cell membrane-binding properties of group A streptococcal lipoteichoic acid
Publicado: (1975)

Tailoring gut immune responses with lipoteichoic acid-deficient Lactobacillus acidophilus
por: Lightfoot, Yaíma L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eormt7cu2q8ga8t9637ha320fu